EPISODE · Sep 20, 2024 · 24 MIN
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
from Keeping Current CME
Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations? Credit available for this activity expires: 9/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001632?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
0:00
24:04
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 24 minutes long.
When was this Keeping Current CME episode published?
This episode was published on September 20, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!